Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-05-18
1995-05-02
Higel, Floyd D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514391, 514342, 5483111, 5483171, 5483185, 5483201, 5483205, C07D23372, A61K 31415
Patent
active
054119812
ABSTRACT:
A compound of the formula ##STR1## wherein R.sub.1 is --CN, --NO.sub.2 or halogen, R.sub.2 is --CF.sub.3 or halogen, --A-B-- is of ##STR2## X is --O-- or --S--, R.sub.3 is hydrogen, alkyl, alkenyl or alkynyl of up to 12 carbon atoms, aryl and aralkyl of up to 12 carbon atoms, all optionally substituted by --OH, halogen, --SH, --CN, acyl and acyloxy of up to 7 carbon atoms, --aryl, --O--aryl, --O--aralkyl --S-- aryl of up to 12 carbon atoms the aryl and aralkyl being optionally substituted by halogen, --CF.sub.3, alkyl, alkoxy, alkenyl, alkenyloxy, alkynyl or alkynyloxy with the sulfur being optionally oxidized to sulfone or sulfoxide, free, esterified, amidified or salified carboxy, --NH.sub.2, mono and dialkylamino and heterocyclic of 3 to 6 ring members and containing at least one heteroatom selected from the group consisting of oxygen, sulfur and nitrogen, the alkyl, alkenyl and alkynyl being optionally interrupted by at least one oxygen, nitrogen or sulfur optionally oxidized to sulfoxide or sulfone, trialkylsilyl with the alkyl having 1 to 6 carbon atoms and acyl and acyloxy of an organic carboxylic acid of 1 to 7 carbon atoms and Y is --O--, --S-- or --NH--, except the compounds wherein --A-B-- is ##STR3## X is oxygen, R.sub.3 is hydrogen and Y is oxygen or --NH--, R.sub.2 is --CF.sub.3 or halogen and R.sub.1 is --NO.sub.2 or halogen and their non-toxic, pharmaceutically acceptable acid addition salts.
REFERENCES:
patent: 3823240 (1974-07-01), Sauli et al.
patent: 4097578 (1978-06-01), Perronet et al.
patent: 4234736 (1980-11-01), Bernauer et al.
patent: 4304782 (1981-12-01), Dymont et al.
patent: 4407814 (1983-10-01), Bernauer et al.
patent: 4427438 (1984-01-01), Nagano et al.
patent: 4473393 (1984-10-01), Nagpal
patent: 4482739 (1984-11-01), Bernauer et al.
patent: 4749403 (1988-06-01), Liebl et al.
patent: 4859228 (1989-08-01), Prisbylla
patent: 4873256 (1989-10-01), Coussediere et al.
patent: 4944791 (1990-07-01), Schroder et al.
patent: 5069711 (1991-12-01), Fischer et al.
Raynaud et al., J. Steriod Biochem., vol. 11, pp. 93-99 (1979).
Rao et al., J. Steriod Biochem., vol. 31, pp. 731-737 (1988).
Gaillard-Kelly Martine
Goubet Francois
Philibert Daniel
Teutsch Jean-Georges
Higel Floyd D.
Roussel Uclaf
LandOfFree
Phenylimidazolidines having antiandrogenic activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Phenylimidazolidines having antiandrogenic activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phenylimidazolidines having antiandrogenic activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1137369